Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia-Reference-Cited by-同舟云学术

Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia

Published:2012-06-07 Issue:1 Volume:20 Page:40-53
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:Eur J Prev Cardiolog

Author:

Stender Steen¹,Budinski Dragos²,Gosho Masahiko³,Hounslow Neil²

Affiliation:

1. University of Copenhagen, Hellerup, Denmark.

2. Kowa Research Europe Ltd, Wokingham, Berkshire, UK.

3. Kowa Company, Tokyo, Japan.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

http://journals.sagepub.com/doi/pdf/10.1177/2047487312451251

Reference28 articles.

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

2. Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

3. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study

4. Lipoprotein Management in Patients With Cardiometabolic Risk

5. The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Randomized Clinical Trials on the Efficacy and Safety of Pitavastatin;Current Reviews in Clinical and Experimental Pharmacology;2023-07

2. Mini-Review on the efficacy and safety of pitavastatin: “The novel seventh statin gaining momentum”;Journal of Pharmacy And Bioallied Sciences;2022

3. A comprehensive review on the lipid and pleiotropic effects of pitavastatin;Progress in Lipid Research;2021-11

4. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses;BMJ;2021-07-14

5. Safety Considerations of Pharmacological Treatment;Stroke Revisited: Dyslipidemia in Stroke;2021